CPAP

UCL-Ventura helping COVID-19 patients in over 15 countries

16 March 2021 | UCLB News

The UCL-Ventura, a low-cost breathing aid developed by UCL, UCLH and Mercedes-AMG High Performance Powertrains, is helping to cut deaths from COVID-19 in hospitals around the world.

Reverse engineered and manufactured in record time at the start of the pandemic, when both ventilators and CPAPs were in short supply, the UCL-Ventura model has now been supplied to around 130 hospitals in the UK and is in use in hospitals in at least 15 other countries.

To support healthcare systems around the world, the designs and manufacturing information for the UCL-Ventura were made freely available online with support from UCL Business, allowing manufacturing teams to develop and gain regulatory approval for the device in their own country.

Read the full story on UCL News.

Find out more about UCL’s COVID-19 research.